ATE162717T1 - Behandlung kardialer dysfunktion mit 15- ketoprostaglandinderivaten - Google Patents

Behandlung kardialer dysfunktion mit 15- ketoprostaglandinderivaten

Info

Publication number
ATE162717T1
ATE162717T1 AT90312640T AT90312640T ATE162717T1 AT E162717 T1 ATE162717 T1 AT E162717T1 AT 90312640 T AT90312640 T AT 90312640T AT 90312640 T AT90312640 T AT 90312640T AT E162717 T1 ATE162717 T1 AT E162717T1
Authority
AT
Austria
Prior art keywords
treatment
dysfunction
ketoprostagland
inderivatives
cardial
Prior art date
Application number
AT90312640T
Other languages
English (en)
Inventor
Ryuji Ueno
Hiroyoshi Osama
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Application granted granted Critical
Publication of ATE162717T1 publication Critical patent/ATE162717T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT90312640T 1989-11-22 1990-11-21 Behandlung kardialer dysfunktion mit 15- ketoprostaglandinderivaten ATE162717T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30384089 1989-11-22

Publications (1)

Publication Number Publication Date
ATE162717T1 true ATE162717T1 (de) 1998-02-15

Family

ID=17925938

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90312640T ATE162717T1 (de) 1989-11-22 1990-11-21 Behandlung kardialer dysfunktion mit 15- ketoprostaglandinderivaten

Country Status (9)

Country Link
EP (1) EP0430551B1 (de)
JP (1) JPH0791191B2 (de)
KR (1) KR0167557B1 (de)
AT (1) ATE162717T1 (de)
CA (1) CA2030346C (de)
DE (1) DE69032000T2 (de)
DK (1) DK0430551T3 (de)
ES (1) ES2113345T3 (de)
GR (1) GR3026105T3 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE401894T1 (de) * 1997-11-28 2008-08-15 Sucampo Ag Verwendung von 15-keto-prostaglandin-e verbindungen als endothelin antagonisten
BRPI0014869B8 (pt) † 1999-10-15 2021-05-25 Sucampo Ag prostaglandinas bicíclicas, composições estabilizadas das mesmas, bem como processo para sua estabilização
US6414016B1 (en) * 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
TWI331920B (en) * 2001-11-14 2010-10-21 Sucampo Ag Unit dosage form for relieving or treating constipation in human patients
US7732487B2 (en) 2001-11-19 2010-06-08 Sucampo Ag Method for treating a disease or condition responsive to opening of C1C-2 channel
KR100804525B1 (ko) 2005-03-24 2008-02-20 삼성에스디아이 주식회사 집적회로 칩용 방열부재 및 이를 구비한 디스플레이 모듈
WO2009104205A1 (en) * 2008-02-20 2009-08-27 Lupin Limited Delayed release formulation of chloride channel activator
CN102028696B (zh) * 2009-09-24 2013-02-13 上海天伟生物制药有限公司 一种前列腺素类化合物的用途
US10457623B1 (en) 2018-07-13 2019-10-29 Chirogate International Inc. Process for the preparation of Lubiprostone and intermediates thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2328132A1 (de) * 1973-05-30 1975-01-02 Schering Ag Neue prostansaeurederivate und verfahren zu ihrer herstellung
JPS581117B2 (ja) * 1976-01-01 1983-01-10 フアイザ−・インコ−ポレ−テツド １１−デオキシ−ω−ペンタノルプロスタグランジン類
JPS5879973A (ja) * 1981-11-09 1983-05-13 Ono Pharmaceut Co Ltd プロスタグランジン誘導体の重合体、その製造方法及び該重合体を有効成分として含有する治療剤
JPS60208917A (ja) * 1984-02-29 1985-10-21 ジ・アツプジヨン・カンパニー Ａｒｄｓおよび多器官不全治療、予防におけるプロスタグランジンの使用
EP0153858A3 (de) * 1984-02-29 1985-12-11 The Upjohn Company Therapeutische Anwendung von Protaglandinen
JP2597629B2 (ja) * 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
JP2597649B2 (ja) * 1988-05-11 1997-04-09 株式会社上野製薬応用研究所 気管・気管支拡張剤
DE68906193T2 (de) * 1988-05-23 1993-08-05 Ueno Seiyaku Oyo Kenkyujo Kk Hypersphyxia verursachende zusammensetzung.
JP2760514B2 (ja) * 1988-07-20 1998-06-04 株式会社 上野製薬応用研究所 循環機能昂進剤

Also Published As

Publication number Publication date
GR3026105T3 (en) 1998-05-29
JPH0791191B2 (ja) 1995-10-04
DK0430551T3 (da) 1998-04-14
EP0430551B1 (de) 1998-01-28
KR0167557B1 (ko) 1999-01-15
CA2030346A1 (en) 1991-05-23
DE69032000D1 (de) 1998-03-05
JPH03218314A (ja) 1991-09-25
KR910009270A (ko) 1991-06-28
EP0430551A3 (en) 1992-07-15
EP0430551A2 (de) 1991-06-05
DE69032000T2 (de) 1998-05-14
CA2030346C (en) 2000-04-11
ES2113345T3 (es) 1998-05-01

Similar Documents

Publication Publication Date Title
ATE169219T1 (de) Behandlung von katarakt mit 15-keto- prostaglandinderivaten
ATE143263T1 (de) Behandlung von neurodegenerativen erkrankungen
DE69130586D1 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
ATE137116T1 (de) Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen
ATE132749T1 (de) Behandlung der hepatobilären erkrankung mit 15- ketoprostaglandin-derivaten
ATE162717T1 (de) Behandlung kardialer dysfunktion mit 15- ketoprostaglandinderivaten
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
IT8420682A1 (it) "Procedimento per il trattamento di articoli di maglieria"
ATE146964T1 (de) Behandlung von katarakt mit prostacyclinverbindungen
DE69124415D1 (de) Verwendung von 15-Dehydroxy-16-Oxoprostaglandin bei der Behandlung von allergischen Erkrankungen
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
NO912745L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,2,5,6-tetrahydropyridinforbindelser.
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
IT1219672B (it) Procedimento per il trattamento di acque di vegetazione
SU1432991A1 (ru) 4-Метил-5-(4-метилфениламино)-1,2,3-триазол, обладающий противовоспалительной активностью
IT8219330A0 (it) Composto medicinale per il trattamento di malattie di cuore.
ATE86857T1 (de) Transdermate magensafthemmende wirkstoffe zur behandlung von magen-darm-erkrankungen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee